|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cardiovascular Disease | |||||
| Coronary Artery Bypass Surgery | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Cardiovascular Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Angiomax (bivalirudin) | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Bivalirudin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anticoagulants | |||||
| Hematologic Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| The Medicines Company | |||||